Polymorphic forms and process

Details for Australian Patent Application No. 2007263393 (hide)

Owner Merck Patent GmbH

Inventors Emde, Ulrich; Schlueter, Tobias; Schiemann, Kai; Saal, Christoph; Maiwald, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2007263393

PCT Pub. Number WO2007/147480

Priority 06012525.9 19.06.06 EP

Filing date 26 May 2007

Wipo publication date 27 December 2007

Acceptance publication date 1 March 2012

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/436 (2006.01)

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2007/147480 Priority application(s): WO2007/147480

1 March 2012 Application Accepted

  Published as AU-B-2007263393

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263405-Multi-switch flashlight

2007263391-3 -amino-imidazo[1, 2-A]pyridine derivatives as SGLT inhibitors